- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07499024
Evaluation of the Diagnostic Performance of the Testicular Workup for Ischemia and Suspected Torsion (TWIST) Score for Assessing the Risk of Testicular Torsion in Adult Patients Presenting to the Emergency Department With Scrotal Pain - A Prospective Observational Study
Evaluation of the Diagnostic Performance of the Testicular Workup for Ischemia and Suspected Torsion (TWIST) Score for Assessing the Risk of Testicular Torsion in Adult Patients Presenting to the Emergency Department With Scrotal Pain
This prospective multicenter observational study aims to evaluate the diagnostic accuracy of the Testicular Workup for Ischemia and Suspected Torsion (TWIST) score in adult patients presenting with acute scrotal pain in Swedish Emergency Departments.
The TWIST score is a clinical decision tool originally validated in pediatric populations to stratify patients into low, intermediate, and high risk for testicular torsion. The study will include men aged 18-40 years presenting with scrotal pain or symptoms suggestive of torsion. Patients with scrotal trauma, symptom duration over one week, previous testicular surgery, or inability to give informed consent in Swedish will be excluded.
Participants' clinical findings will be recorded on a standardized form, and the TWIST score will be calculated. Management will follow standard clinical practice independently of the study. Primary outcome is the diagnostic accuracy of the TWIST score to rule out testicular torsion in low-risk patients (TWIST 0-2). Secondary outcomes include diagnosis of torsion within 30 days, time to surgery, patient-reported pain, number of Doppler ultrasounds performed, and the potential reduction in unnecessary imaging.
The study will be conducted at multiple Swedish sites, including Linköping University Hospital, under oversight by the Swedish Ethical Review Authority (Etikprövningsmyndigheten, decision number 2025-07400-01). The results aim to inform clinical practice by providing a validated decision-support tool for adult patients with suspected testicular torsion, potentially improving patient outcomes and resource utilization.
Study Overview
Status
Conditions
Detailed Description
Acute scrotal pain is a common presentation in Emergency Departments, but the diagnosis of testicular torsion (TT) is relatively rare. Prompt identification is crucial because TT requires urgent surgical intervention to preserve testicular viability. Delays in diagnosis, particularly due to unnecessary imaging or non-standardized clinical assessment, may result in testicular loss.
The TWIST (Testicular Workup for Ischemia and Suspected Torsion) score is a clinical decision tool developed and validated in pediatric populations to stratify risk of TT based on five clinical features: testicular swelling, hard testis, high-riding testis, absent cremasteric reflex, and nausea/vomiting. Adult validation is limited, and no large-scale multicenter study has evaluated its performance in adult Emergency Department settings in Sweden.
This study will prospectively collect structured clinical data from adult patients aged 18-40 years presenting with scrotal pain at participating Swedish EDs. The TWIST score will be calculated from documented clinical findings. The study does not influence clinical management; patients will receive standard care, including imaging or surgical intervention as deemed appropriate by treating clinicians.
Primary objectives focus on the diagnostic accuracy of TWIST for ruling out TT in low-risk patients, while secondary objectives include assessment of the score in identifying high-risk patients, measurement of time to surgery, evaluation of pain scores, and analysis of imaging utilization. Data will also be linked to the Swedish Perioperative Register (SPOR) for outcomes such as surgery performed, complications, and final diagnoses.
The study is designed to evaluate whether structured use of TWIST can support evidence-based, standardized risk stratification in adults, potentially improving patient outcomes, streamlining resource use, and reducing unnecessary delays in diagnosis and treatment. Ethical oversight is provided by the Swedish Ethical Review Authority (Etikprövningsmyndigheten, decision 2025-07400-01).
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Jens Wretborn, MD, PhD
- Phone Number: +461030000
- Email: jens.wretborn@liu.se
Study Locations
-
-
Östergötland County
-
Linköping, Östergötland County, Sweden, 58185
- Recruiting
- Linköping University Hospital, ED
-
Contact:
- Jens Ragnar Wretborn, MD, PhD
- Phone Number: +46
- Email: jens.wretborn@liu.se
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Male patients aged 18-40 years
Presenting to the Emergency Department with acute scrotal pain or scrotal symptoms
Suspicion of testicular torsion before clinical assessment
Exclusion Criteria:
- Scrotal pain or symptoms caused by trauma
Symptom duration > 1 week
History of testicular surgery
Inability to provide informed consent (e.g., language barrier or cognitive limitation)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Adult ED Patients with Acute Scrotal Pain
All participants are assessed according to routine clinical care in the Emergency Department. The TWIST score is calculated from standard clinical findings but does not influence management; decisions regarding imaging or surgery follow usual clinical practice. Data on symptoms, TWIST score components, and outcomes (including surgical confirmation of testicular torsion) are collected prospectively. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diagnostic Accuracy of the TWIST Score (Low-Risk Group)
Time Frame: Up to 30 days from ED visit
|
Number and proportion of adult patients with a low-risk TWIST score (0-2) who are confirmed not to have testicular torsion based on surgical exploration or follow-up within 30 days.
This measures the sensitivity of the TWIST score to safely rule out torsion.
|
Up to 30 days from ED visit
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time to exploration
Time Frame: 30 days from ED visit
|
Time in hours from patient arrival in the Emergency Department to surgical intervention for suspected testicular torsion.
|
30 days from ED visit
|
|
Testicular torsion
Time Frame: 30 days from inclusion
|
Number of testicular torsions found up to 30 days from ED visit
|
30 days from inclusion
|
|
Pain at study inclusion
Time Frame: Up to one hour from inclusion in the study.
|
Pain at inclusion to the study measured by NRS
|
Up to one hour from inclusion in the study.
|
|
Use of Ultrasound
Time Frame: Up to 48 hours from inclusion or ED discharge, whichever comes first
|
If ultrasound was used during the Emergency Department visit
|
Up to 48 hours from inclusion or ED discharge, whichever comes first
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Jens Wretborn, MD, PhD, Linkoeping University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2025-07400-01 (Other Identifier: Swedish Ethical Review Authority approval number)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Scrotum
-
University of Texas Southwestern Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedAcute Scrotum | Testicular TorsionUnited States
-
Sheffield Children's NHS Foundation TrustRecruitingTorsion Testis | Scrotum DiseaseUnited Kingdom
-
Nicolai Skov SchiellerupNot yet recruiting
-
Fujian Medical University Union HospitalFirst Affiliated Hospital of Wenzhou Medical University; Quanzhou First Hospital and other collaboratorsRecruitingPaget Disease, Extramammary | Scrotum DiseaseChina
-
Fudan UniversityFujian Province Tumor Hospital; Qinghai Province Cancer HospitalRecruitingExtramammary Paget Disease | Scrotum DiseaseChina
-
University of ManitobaCompletedAnesthesia, Local | Spermatocele | Scrotum Disease | Hydrocele Male | Scrotal HematoceleCanada
-
Hospital Universitario Dr. Jose E. GonzalezCompletedFournier Gangrene | Fournier's Gangrene of Penis | Fournier's Gangrene of ScrotumMexico
-
University of ManitobaRecruitingLocal Anesthesia | Spermatocele | Scrotum Disease | Hydrocele Male | Scrotal HematoceleCanada
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedChildhood Acute Erythroleukemia (M6) | Childhood Acute Megakaryocytic Leukemia (M7) | Childhood Acute Monoblastic Leukemia (M5a) | Childhood Acute Monocytic Leukemia (M5b) | Childhood Acute Myeloblastic Leukemia With Maturation (M2) | Childhood Acute Myeloblastic Leukemia Without Maturation... and other conditionsUnited States
-
National Cancer Institute (NCI)TerminatedAdult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic Leukemia Without Maturation... and other conditionsUnited States